Drugs Information: Golimumab
Basic Information
|
||
| ID | DDInter837 | |
| Drug Type | biotech | |
| Molecular Formula | C6530H10068N1752O2026S44 | |
| Molecular Weight | - | |
| Description | Golimumab is a TNFα inhibitor used in the symptomatic treatment of various active inflammatory disorders, such as rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, and ulcerative colitis. | |
| ATC Classification | L04AB06 | |
| IUPAC Name | None | |
| InChI | None | |
| InChI Key | None | |
| Canonical SMILES | None | |
| Useful Links | DrugBank | |
Interactions with Golimumab
| Severity level | ID | Name | Mechanism | Detail |
|---|